Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Technical Reports

CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4°C does not affect outcome

Abstract

The purpose of this study was to investigate whether storing mobilized peripheral blood progenitor cell (PBPC) collections overnight before CD34+ selection may delay platelet count recovery after high-dose chemotherapy and CD34+-enriched PBPC re-infusion. Lymphoma patients underwent PBPC mobilization with cyclophosphamide 4 g/m2 i.v. and G-CSF 10 μg/kg/day subcutaneously. Patients were prospectively randomized to have each PBPC collection enriched for CD34+ cells with the CellPro CEPRATE SC System either immediately or after overnight storage at 4°C. Thirty-four patients were randomized to overnight storage and 34 to immediate processing of PBPC; 15 were excluded from analysis due to tumor progression or inadequate CD34+ cell mobilization. PBPC from 23 patients were stored overnight, while 30 subjects underwent immediate CD34+selection and cryopreservation. Median yield of CD34+ enrichment was 43.6% in the immediate processing group compared to 39.1% in the overnight storage group (P = 0.339). neutrophil recovery >500 × 109/l occurred a median of 11 days (range 9–16 days) in the overnight storage group compared to 10.5 days (range 9–21 days) in the immediate processing group (P = 0.421). Median day to platelet transfusion independence was 13 (range 7–43) days in the overnight storage group vs 13.5 (range 8–35) days in those assigned to immediate processing (P = 0.933). We conclude that storage of PBPC overnight at 4°C allows pooling of consecutive-day collections resulting in decreased costs and processing time without compromising neutrophil and platelet engraftment after infusion of CD34+-selected progenitor cells. Bone Marrow Transplantation (2000) 25, 559–566.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Armitage JO . Bone marrow transplantation New Engl J Med 1994 330: 827–838

    Article  CAS  PubMed  Google Scholar 

  2. Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients Lancet 1996 347: 353–357

    Article  CAS  PubMed  Google Scholar 

  3. Léonard BM, Hétu F, Busque L et al. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources Blood 1998 91: 331–339

    PubMed  Google Scholar 

  4. Ross AA, Cooper BW, Lazarus HM et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques Blood 1993 82: 2605–2610

    CAS  PubMed  Google Scholar 

  5. Sharp JG, Kessinger A, Mann S et al. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest J Clin Oncol 1996 14: 214–221

    Article  CAS  PubMed  Google Scholar 

  6. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation Lancet 1993 341: 85–86

    Article  CAS  PubMed  Google Scholar 

  7. Negrin RS, Kusnierz-Glaz CR, Still BJ et al. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma Blood 1995 85: 3334–3341

    CAS  PubMed  Google Scholar 

  8. Gribben JG, Neuberg D, Freeman AS et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B cell lymphoma Blood 1993 81: 3449–3457

    CAS  PubMed  Google Scholar 

  9. Deisseroth A, Zu Z, Claxton D et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML Blood 1994 83: 3068–3076

    CAS  PubMed  Google Scholar 

  10. Moolten DN . Peripheral blood stem cell transplant: future directions Semin Oncol 1995 22: 271–290

    CAS  PubMed  Google Scholar 

  11. Demirer T, Gooley T, Buckner CD et al. Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation Bone Marrow Transplant 1995 15: 907–913

    CAS  PubMed  Google Scholar 

  12. Rizzi S, Motta MR, Fortuna M et al. Positive selection and transplantation of autologous hematopoietic CD34+ cells after myeloblative therapy. Twenty First Annual Meeting of EBMT Davos, Switzerland, 1995.

  13. Stewart AK, Vescio R, Schiller G et al. Phase III study evaluating CD34 selected versus unselected autologous peripheral blood progenitor cell transplantation in 190 patients with advanced multiple myeloma Blood 1998 92: (Suppl. 1) 662a

    Google Scholar 

  14. Franklin W, Shpall E, Archer P et al. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support Breast Cancer Res 1996 41: 1–13

    Article  CAS  Google Scholar 

  15. Gorin NC, Lopez M, Laporte JP et al. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma Blood 1995 85: 1647–1654

    CAS  PubMed  Google Scholar 

  16. Holland HK, Fleming WH, Waller EK et al. Selection and transplantation of autologous CD34+ peripheral blood stem cells in non-Hodgkin's lymphoma using high-speed fluorescence-activated cell sorting Blood 1998 88: (Suppl. 1) 407a

    Google Scholar 

  17. Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma New Engl J Med 1991 325: 1525–1533

    Article  CAS  PubMed  Google Scholar 

  18. Koç ON, Gerson SL, Phillips GL et al. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment Bone Marrow Transplant 1998 21: 337–343

    Article  PubMed  Google Scholar 

  19. Bensinger WI . Editorial. Should we purge? Bone Marrow Transplant 1998 21: 113–115

    Article  CAS  PubMed  Google Scholar 

  20. A predictive model for aggressive non-Hodgkin's lymphoma . The International Non-Hodgkin's Lymphoma Prognostic Factors Project New Engl J Med 1993 329: 987–994

    Article  Google Scholar 

  21. Bender JG, Unverzagt K, Walker D . Guidelines for determination of CD34+ cells by flow cytometry: application to the harvesting and transplantation of peripheral blood stem cells. In: Wunder E, Sovalat H, Hénon P, Serke S (eds) Hematopoietic Stem Cells. The Mulhouse Manual AlphaMed Press: Dayton, OH 1994 pp 31–43

    Google Scholar 

  22. Lazarus HM, Crilley P, Ciobanu N et al. High-dose carmustine, etoposide, cisplatin (BEP) and autologous bone marrow transplantation for relapsed and refractory lymphoma J Clin Oncol 1992 10: 1682–1689

    Article  CAS  PubMed  Google Scholar 

  23. Gingrich RD, Ginder GD, Burns LJ et al. BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma Blood 1990 75: 2276–2281

    CAS  PubMed  Google Scholar 

  24. Mills W, Chopra R, McMillan A et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma J Clin Oncol 1995 13: 588–595

    Article  CAS  PubMed  Google Scholar 

  25. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design Br J Cancer 1976 34: 585–612

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Armitage JO . Treatment of non-Hodgkin's lymphoma New Engl J Med 1993 328: 1023–1030

    Article  CAS  PubMed  Google Scholar 

  27. Sharp JG, Joshi SS, Armitage JO et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique Blood 1992 79: 1074–1080

    CAS  PubMed  Google Scholar 

  28. Lazarus HM, Rowe JM, Goldstone AH . Does in vitro purging improve the outcome after autologous bone marrow transplantation? J Hematother 1994 2: 457–466

    Article  Google Scholar 

  29. Beaujean F, Pico J, Norol F et al. Characteristics of peripheral blood progenitor cells frozen after 24 hours of liquid storage J Hematother 1996 5: 681–686

    Article  CAS  PubMed  Google Scholar 

  30. Pettengell R, Woll PJ, O'Connor DA et al. Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: effects of storage media, temperature and time Bone Marrow Transplant 1994 14: 703–709

    CAS  PubMed  Google Scholar 

  31. Hechler G, Weide R, Heymanns J et al. Storage of noncryopreserved peripheral blood stem cells for transplantation Ann Hematol 1996 72: 303–306

    Article  CAS  PubMed  Google Scholar 

  32. Jestice HK, Scott MA, Ager S et al. Liquid storage of peripheral blood progenitor cells for transplantation Bone Marrow Transplant 1994 14: 991–994

    CAS  PubMed  Google Scholar 

  33. Lane TA, Young D, Mullen M et al. Effect of storage on engraftment of mobilized peripheral blood progenitor cells Blood 1997 90: (Suppl. 2) 329b

    Google Scholar 

  34. Sugrue MW, Hutcheson CE, Fisk DD et al. The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery and cost J Hematother 1998 7: 431–436

    Article  CAS  PubMed  Google Scholar 

  35. Chabannon C, Moatti J-P, Maraninchi D . Will CD34+ standardization solve all problems related to cell therapy? (letter) J Hematother 1997 6: 439–440

    Article  CAS  PubMed  Google Scholar 

  36. Watts MJ, Sullivan AM, Leverett D et al. Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization J Clin Oncol 1998 16: 1554–1560

    Article  CAS  PubMed  Google Scholar 

  37. Weaver CH, Tauer K, Zhen B et al. Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields J Hematother 1998 7: 241–249

    Article  CAS  PubMed  Google Scholar 

  38. Moskowitz CH, Glassman JR, Wuest D et al. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma Clin Cancer Res 1998 4: 311–316

    CAS  PubMed  Google Scholar 

  39. Brugger W, Bross KJ, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors Blood 1994 83: 623–640

    Google Scholar 

  40. Kahn DG, Prilutskaya M, Cooper B et al. The relationship between the incidence of tumor contamination and number of phereses for stage IV breast cancer Blood 1997 90: (Suppl. 1) 565a

    Google Scholar 

Download references

Acknowledgements

We thank Howard J Meyerson, MD, for flow cytometric study assistance, and Donna Speron, Lisa McDonnel, and Cindy Jacobs, PhD, MD for their expert support in the conduct of this protocol and in the preparation of the manuscript. This work was supported, in part, by a grant from CellPro, Inc., Bothell, WA, and Public Health Service grants M01RR00080, P30CA43703, and P30CA16086 from the National Institutes of Health, the National Cancer Institute and the Department of Health and Human Services.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lazarus, H., Pecora, A., Shea, T. et al. CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4°C does not affect outcome. Bone Marrow Transplant 25, 559–566 (2000). https://doi.org/10.1038/sj.bmt.1702175

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702175

Keywords

This article is cited by

Search

Quick links